cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Supernus Pharmaceuticals Inc
11 own
18 watching
Current Price
$41.61
$-0.42
(-1%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
2,249.17M
52-Week High
52-Week High
42.09
52-Week Low
52-Week Low
24.95
Average Volume
Average Volume
0.55M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
21.4016
iconMarket Capitalization2,249.17M
icon52-Week High42.09
icon52-Week Low24.95
iconAverage Volume0.55M
iconDividend Yield--
iconP/E Ratio21.4016
What does the Supernus Pharmaceuticals Inc do?
Supernus Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system diseases in the United States. It offers Oxtellar XR, an extended-release oxcarbazepine for use in the treatment of epilepsy; and Trokendi XR, an extended-release topiramate, which is used for the treatment of epilepsy. The company's product candidates comprise SPN-810, a molindone hydrochloride that is in Phase III clinical trial for the treatment of impulsive aggression in patients with attention deficit hyperactivity disorder (ADHD); and SPN-812, a viloxazine hydrochloride, which has completed Phase IIb trial that is used for the treatment of ADHD. It also develops SPN-809, a viloxazine hydrochloride, which is in Phase II ready clinical trial for the treatment of depression. The company markets its products through wholesalers and pharmaceutical distributors. Supernus Pharmaceuticals, Inc. was founded in 2005 and is based in Rockville, Maryland.
Read More
How much money does Supernus Pharmaceuticals Inc make?
News & Events about Supernus Pharmaceuticals Inc.
PR Newswire
3 months ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN PR Newswire NEW YORK, Nov. 4, 2022 NEW YORK, Nov. 4...
Globe Newswire
3 months ago
NEW YORK, Oct. 30, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Supernus Pharmaceuticals, Inc. (Supernus or the Company) (NASDAQ:SUPN). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The ...
PR Newswire
3 months ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN PR Newswire NEW YORK, Oct. 26, 2022 NEW YORK, Oct. 26...
PR Newswire
3 months ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN PR Newswire NEW YORK, Oct. 19, 2022 NEW YORK, Oct. 19...
Globe Newswire
3 months ago
NEW YORK, Oct. 14, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Supernus Pharmaceuticals, Inc. (Supernus or the Company) (NASDAQ:SUPN). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The ...
Frequently Asked Questions
Frequently Asked Questions
What is Supernus Pharmaceuticals Inc share price today?
plus_minus_icon
Can Indians buy Supernus Pharmaceuticals Inc shares?
plus_minus_icon
How can I buy Supernus Pharmaceuticals Inc shares from India?
plus_minus_icon
Can Fractional shares of Supernus Pharmaceuticals Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Supernus Pharmaceuticals Inc stocks?
plus_minus_icon
What is today’s traded volume of Supernus Pharmaceuticals Inc?
plus_minus_icon
What is today’s market capitalisation of Supernus Pharmaceuticals Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Supernus Pharmaceuticals Inc?
plus_minus_icon
What percentage is Supernus Pharmaceuticals Inc down from its 52-Week High?
plus_minus_icon
What percentage is Supernus Pharmaceuticals Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$41.61
$-0.42
(-1%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00